Intraocular pressure control and long-term visual field loss in the Collaborative Initial Glaucoma Treatment Study.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Ophthalmology (Rochester, Minn.)

• Publication date

  2011-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ophtha.2011.01.047PMID 21600658PMCID PMC3161134
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Assessing the efficacy of latanoprost vs timolol using an alternate efficacy parameter: the intervisit intraocular pressure range.

  2009cited by this paper
• Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors.

  2009cited by this paper
• Smoothing the intraocular pressure roller coaster: a new goal?

  2009cited by this paper
• Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.

  2008cited by this paper
• Intraocular Pressure Fluctuation : A Risk Factor for Visual Field Progression at Low Intraocular Pressures in the Advanced Glaucoma Intervention Study

  2008cited by this paper
• Factors associated with intraocular pressure before and during 9 years of treatment in the Collaborative Initial Glaucoma Treatment Study.

  2008cited by this paper
• Inter-visit intraocular pressure range: an alternative parameter for assessing intraocular pressure control in clinical trials.

  2008cited by this paper
• Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial.

  2007cited by this paper
• Intraocular pressure fluctuation: an independent risk factor for glaucoma?

  2007cited by this paper
• Predictors of long-term progression in the early manifest glaucoma trial.

  2007cited by this paper
• Association between intraocular pressure variation and glaucoma progression: data from a United States chart review.

  2007cited by this paper
• Long-term intraocular pressure fluctuation and progressive visual field deterioration in patients with glaucoma and low intraocular pressures after a triple procedure.

  2007cited by this paper
• 24-hour intraocular pressure control with maximum medical therapy compared with surgery in patients with advanced open-angle glaucoma.

  2006cited by this paper
• Prevalence of open-angle glaucoma among adults in the United States.

  2004cited by this paper
• Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study.

  2004cited by this paper
• Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial.

  2003cited by this paper
• The collaborative initial glaucoma treatment study: baseline visual field and test-retest variability.

  2003cited by this paper
• Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.

  2002cited by this paper
• The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma.

  2002cited by this paper
• Confirmation of visual field abnormalities in the Ocular Hypertension Treatment Study. Ocular Hypertension Treatment Study Group.

  2000cited by this paper
• Factors associated with long-term progression or stability in primary open-angle glaucoma.

  2000cited by this paper
• Classification of visual field abnormalities in the ocular hypertension treatment study.

  2000cited by this paper
• The advanced glaucoma intervention study (AGIS): 7. the relationship between control of intraocular pressure and visual field deterioration

  2000cited by this paper
• The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators.

  2000cited by this paper
• Impact of intraocular pressure regulation on visual fields in open-angle glaucoma.

  1999cited by this paper
• The Collaborative Initial Glaucoma Treatment Study: study design, methods, and baseline characteristics of enrolled patients.

  1999cited by this paper
• The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group.

  1998cited by this paper
• Detection of incident field loss using the glaucoma hemifield test.

  1996cited by this paper
• Standardizing the measurement of intraocular pressure for clinical research. Guidelines from the Eye Care Technology Forum.

  1996cited by this paper
• Standardizing the measurement of visual fields for clinical research: Guidelines from the Eye Care Technology Forum.

  1996cited by this paper
• Factors associated with visual loss in patients with advanced glaucomatous changes in the optic nerve head.

  1993cited by this paper
• The Risk of Determining Risk with Multivariable Models

  1993cited by this paper
• Intraocular pressure and the rate of visual field loss in chronic open-angle glaucoma.

  1991cited by this paper
• The quality of medical evidence: implications for quality of care.

  1988cited by this paper
• Longitudinal data analysis using generalized linear models

  1986cited by this paper
• Random-effects models for longitudinal data.

  1982cited by this paper
• Trabeculectomy and the progression of glaucomatous visual field loss.

  1977cited by this paper

• A comparison of water drinking test among normotensive and ocular hypertensive eyes with pseudoexfoliation.

  2026cites this paper
• Effect of the Support, Educate, Empower Personalized Glaucoma Coaching Program on Medication Adherence: The SEE Program Randomized Clinical Trial.

  2026cites this paper
• Influence of Intraocular Pressure on Clinical Decision-Making in Glaucoma Management

  2026cites this paper
• Deep Learning-Based Prediction of Visual Field Mean Deviation from Numeric OCT Data in Glaucoma.

  2026cites this paper
• Outcomes of the 63-μm Gelatin Microstent versus 45-μm Gelatin Microstent: An International Multi-Center Study.

  2026cites this paper
• Relationship Between Intraocular Pressure and the True Rate of Functional and Structural Progression in the United Kingdom Glaucoma Treatment Study

  2025cites this paper
• Machine-learning-based automated Schlemm’s canal volumetric segmentation for optical coherence tomography

  2025cites this paper
• Maximum Tolerated Medical Therapy for Glaucoma: Fixed-Dose Combinations of Timolol, Dorzolamide, Brimonidine with Latanoprost Versus Timolol, Dorzolamide with Latanoprost

  2025cites this paper
• Pattern of Long Term Intraocular Pressure Variation following Gonioscopy-assisted Transluminal Trabeculotomy: Two-year Outcomes.

  2025cites this paper
• Early adoption of a novel initial treatment paradigm for open-angle glaucoma: an evidence-based model

  2025cites this paper
• Long-Term Surgical Outcome of Trabeculectomy with Mitomycin C: A Comparison Between Primary and Secondary Glaucoma in Thailand

  2025cites this paper
• Validation of iCare IC200® rebound tonometry for intraocular pressure measurement.

  2025cites this paper
• Interventional glaucoma consensus treatment protocol

  2025cites this paper
• Predictive modeling of rapid glaucoma progression based on systemic data from electronic medical records

  2025cites this paper
• Determinants of blindness from glaucoma among patients receiving treatment: a retrospective cohort study in Enugu, Nigeria

  2025cites this paper
• Glaucoma diagnosis and treatment in the era of precision medicine.

  2025cites this paper
• Netarsudil v/s Ripasudil: The battle of supremacy between two ROCKS-I (rho kinase inhibitors)

  2025cites this paper
• Real world outcomes of Kahook Dual Blade goniotomy in black and Afro-Latinx adult patients with glaucoma: a 2-year retrospective study

  2025cites this paper
• Robotic Visible-Light Optical Coherence Tomography Visualizes Segmental Schlemm's Canal Anatomy and Segmental Pilocarpine Response

  2025cites this paper
• Treating Glaucoma in Intellectually Disabled Patients: Novel Criteria for Choosing Surgical Candidates

  2025cites this paper
• Reliability of Self-Monitoring of Intraocular Pressure With iCare Home2 Rebound Tonometry

  2025cites this paper
• Pharmacogenetic Influences on Individual Responses to Ocular Hypotensive Agents in Glaucoma Patients

  2025cites this paper
• Efficacy and Drug Interactions of Glaucoma Medications: A Systematic Review and Component Network Meta-Analysis.

  2025cites this paper
• Deep Learning–Based Prediction of Glaucoma Severity and Progression Using Imo/TEMPO Screening Program

  2025cites this paper
• Filtrierende Glaukomchirurgie – Verfahren mit Bildung eines Filterkissens

  2024cites this paper
• Robotic Visible-Light Optical Coherence Tomography Visualizes Segmental Schlemm’s Canal Anatomy and Segmental Pilocarpine Response

  2024cites this paper
• Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension.

  2024cites this paper
• Standalone interventional glaucoma: evolution from the combination-cataract paradigm

  2024cites this paper
• Machine Learning Models for Predicting 24-Hour Intraocular Pressure Changes: A Comparative Study

  2024cites this paper
• Comparison of baseline clinical characteristics and patterns of visual field defects between high-tension and normal-tension glaucoma

  2024cites this paper
• Short-term outcomes of Tanito microhook ab interno trabeculotomy combined with phacoemulsification in primary open-angle glaucoma – A pilot study

  2024cites this paper
• Main morphofunctional correlations between indicators of intraocular pressure fluctuations and glaucomatous optic neuropathy progression

  2024cites this paper
• Preserflo MicroShunt versus Trabeculectomy: Efficacy and Surgical Success within a Heterogenous Patient Cohort

  2024cites this paper
• Relationship between intraocular pressure fluctuation and visual field progression rates in the United Kingdom Glaucoma Treatment Study.

  2024cites this paper
• Genetic association of lipid traits and lipid-related drug targets with normal tension glaucoma: a Mendelian randomization study for predictive preventive and personalized medicine

  2024cites this paper
• Effectiveness and safety of istent inject as an interventional glaucoma approach for uncontrolled open-angle glaucoma

  2024cites this paper
• Ten-Year Effectiveness and Safety of Trabecular Micro-Bypass Stent Implantation with Cataract Surgery in Patients with Glaucoma or Ocular Hypertension

  2024cites this paper
• Trabeculectomy vs. Tube shunt surgery for the treatment of open-angle glaucoma: current understanding and evolving use of procedures

  2024cites this paper
• Test-Retest Reliability of Intraocular Pressure Measurements With Office-Based Versus Home-Based Rebound Tonometers

  2024cites this paper
• Association of Long-term Intraocular Pressure Variability and Rate of Ganglion Complex Thinning in Patients with Glaucoma.

  2024cites this paper
• The relationship between intraocular pressure and glaucoma: an evolving concept.

  2024cites this paper
• Functional and Morphological Outcomes after Trabeculectomy and Deep Sclerectomy—Results from a Monocentric Registry Study

  2024cites this paper
• To identify risk factors for central visual field progression in moderate to advanced glaucoma

  2024cites this paper
• Reduced Aqueous Humor Outflow Pathway Arborization in Childhood Glaucoma Eyes

  2024cites this paper
• Disparities in Glaucoma Surgery: A Review of Current Evidence and Future Directions for Improvement

  2023cites this paper
• A Brief Review of Historical and Current Trends in Trabeculectomy

  2023cites this paper
• Efecto de la Trabeculoplastía Láser Selectiva en Población Mexicana con Glaucoma Primario de Ángulo Abierto

  2023cites this paper
• Effect of Selective Laser Trabeculoplasty in a Mexican Population with Primary Open-angle Glaucoma

  2023cites this paper
• Twenty-Four-Hour Intraocular Pressure in Chronic Primary Angle-Closure Disease

  2023cites this paper
• Predictors of glaucomatous progression in individuals with small and large optic discs.

  2023cites this paper
• 24-Hour Monitoring of Intraocular Pressure Fluctuations Using a Contact Lens Sensor: Diagnostic Performance for Glaucoma Progression

  2023cites this paper
• Ocular surface and glaucoma, a mutual relationship. Practical suggestions for classification and management.

  2023cites this paper
• Cost-utility analysis of a medication adherence-enhancing educational intervention for glaucoma.

  2023cites this paper
• The impact of achieving target intraocular pressure on glaucomatous retinal nerve fiber layer thinning in a treated clinical population.

  2023cites this paper
• Ocular Biomechanics and Glaucoma

  2023cites this paper
• Advancements in Wearable and Implantable Intraocular Pressure Biosensors for Ophthalmology: A Comprehensive Review

  2023cites this paper
• A potential primary endpoint for clinical trials in glaucoma neuroprotection

  2023cites this paper
• Ocular surface changes in primary open-angle glaucoma on anti-glaucoma medications versus treatment-naïve patients

  2023cites this paper
• Changing from preserved, to preservative-free cyclosporine 0.1% enhanced triple glaucoma therapy: impact on ocular surface disease—a randomized controlled trial

  2023cites this paper
• Glaucoma Trials Simplified

  2023cites this paper
• Understanding racial disparities of glaucoma

  2023cites this paper
• Pharmacotherapy of glaucoma in terms of evidence-based medicine

  2023cites this paper
• Degeneration of retina-brain components and connections in glaucoma: Disease causation and treatment options for eyesight preservation

  2022cites this paper
• Current practice of trabeculectomy in a cohort of experienced glaucoma surgeons in Australia and New Zealand

  2022cites this paper
• The Efficacy of Atelocollagen to Inhibit Fibrotic Proliferation in Tenon Tissue: In vitro Study

  2022cites this paper
• Clinical Practice Management of Primary Open-Angle Glaucoma in the United States: An Analysis of Real-World Evidence

  2022cites this paper
• Complications and post-operative interventions in XEN45 gel stent implantation in the treatment of open angle glaucoma—a systematic review and meta-analysis

  2022cites this paper
• Clinical Practice Management of Primary Open-Angle Glaucoma in the United States: An Analysis of Real-World Evidence Patient

  2022cites this paper
• Standalone XEN45 Gel Stent implantation in the treatment of open- angle Glaucoma: A systematic review and meta-analysis.

  2022cites this paper
• The surgical management of glaucoma: A review

  2022cites this paper
• Factors Associated With Differences in the Initial Location of Structural Progression in Normal-Tension Glaucoma

  2022cites this paper
• Serum complement component 3, complement component 4 and complement component 1q levels predict progressive visual field loss in older women with primary angle closure glaucoma

  2022cites this paper
• Association of an Objective Structural and Functional Reference Standard for Glaucoma with Quality-of-Life Outcomes.

  2022cites this paper
• Clinical Practice Management of Primary Open-Angle Glaucoma in the United States: An Analysis of Real-World Evidence Patient

  2022cites this paper
• Parafoveal vessel Density Dropout May Predict Glaucoma Progression in The Long-Term Follow Up

  2022cites this paper
• Corneal Hysteresis for the Diagnosis of Glaucoma and Assessment of Progression Risk: A Report by the American Academy of Ophthalmology.

  2022cites this paper
• Identifying central 10° visual subfield associated with future worsening of visual acuity in eyes with advanced glaucoma

  2022cites this paper
• Posture-induced changes in intraocular pressure after ab externo XEN45 gel-stent implantation in patients with primary open-angle glaucoma

  2022cites this paper
• Association of Intraocular Pressure With Retinal Nerve Fiber Layer Thinning in Patients With Glaucoma.

  2022cites this paper
• Smart Contact Lenses for the New Era of IoT: Integrated Biosensors, Circuits, and Human–Machine Interface Systems

  2022cites this paper
• Ocular Pulse Amplitude Correlates With Ocular Rigidity at Native IOP Despite the Variability in Intraocular Pulse Volume With Each Heartbeat

  2022cites this paper
• Clinical Ocular Biomechanics: Where Are We after 20 Years of Progress?

  2022cites this paper
• On the optimal values of «target» intraocular pressure

  2022cites this paper
• What Is It About Intraocular Pressure That Matters in Glaucoma Progression?

  2022cites this paper
• What Are the Factors Associated with the Structural Damage Differences in Open-Angle Glaucoma? RNFL- and GCIPL-Dominant Progression

  2022cites this paper
• Will the PRESERFLO™ MicroShunt impact the future of trabeculectomy practice? A UK and Éire Glaucoma Society National Survey

  2022cites this paper
• Comparison of intraocular pressure variability detected by day diurnal variation to that evoked by water drinking

  2021cites this paper
• Changes in intraocular pressures associated with inhalational and mixed anesthetic agents currently used in ophthalmic surgery

  2021cites this paper
• Standalone XEN45 Gel Stent implantation versus combined XEN45-phacoemulsification in the treatment of open angle glaucoma—a systematic review and meta-analysis

  2021cites this paper
• Differences in the eyelid and buccal microbiome of glaucoma patients receiving long-term administration of prostaglandin analog drops

  2021cites this paper
• Sympathetic context of the disease - a new era in glaucoma management

  2021cites this paper
• OPTH_A_288180 583..590

  2021cites this paper
• Active Pharmacovigilance in Peruvian Population: Surveillance of a Timolol/Brimonidine/Dorzolamide Ophthalmic Fixed Combination

  2021cites this paper
• Changes in peripapillary and macular vascular density after laser selective trabeculoplasty: an optical coherence tomography angiography study

  2021cites this paper
• Reoperation Rates and Disease Costs for Primary Open-Angle Glaucoma Patients in the US Treated with Incisional Glaucoma Surgery.

  2021cites this paper
• Circumferential trabecular meshwork cell density in the human eye.

  2021cites this paper
• Longitudinal Growth Differentiation Factor 15 (GDF15) and Long-term Intraocular Pressure Fluctuation in Glaucoma: A Pilot Study

  2021cites this paper
• Infographic: Collaborative Initial Glaucoma Treatment Study (CIGTS)

  2021cites this paper
• Comparison of 12-month surgical outcomes of ab interno trabeculotomy with phacoemulsification between spatula-shaped and dual-blade microhooks

  2021cites this paper
• Therapeutic Drugs and Devices for Tackling Ocular Hypertension and Glaucoma, and Need for Neuroprotection and Cytoprotective Therapies

  2021cites this paper